| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |